Q1 EPS Estimates for Astrana Health Lowered by William Blair

Astrana Health, Inc. (NASDAQ:ASTH) – Investment analysts at William Blair cut their Q1 2025 earnings per share estimates for Astrana Health in a research note issued on Thursday, February 27th. William Blair analyst R. Daniels now anticipates that the company will earn $0.21 per share for the quarter, down from their previous estimate of $0.29. The consensus estimate for Astrana Health’s current full-year earnings is $1.15 per share. William Blair also issued estimates for Astrana Health’s Q2 2025 earnings at $0.34 EPS, Q3 2025 earnings at $0.43 EPS, Q4 2025 earnings at $0.37 EPS and FY2025 earnings at $1.34 EPS.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings results on Thursday, February 27th. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The company had revenue of $665.21 million during the quarter, compared to analyst estimates of $617.24 million.

Several other brokerages also recently weighed in on ASTH. Macquarie raised Astrana Health to a “hold” rating in a research report on Monday, December 16th. Bank of America decreased their price objective on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating for the company in a research report on Tuesday. Robert W. Baird lowered their price objective on Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a research note on Monday. Truist Financial decreased their price target on shares of Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a research report on Monday, January 13th. Finally, Stifel Nicolaus cut their price target on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $56.83.

Astrana Health Stock Up 1.1 %

Shares of NASDAQ:ASTH opened at $26.78 on Monday. Astrana Health has a 1 year low of $23.12 and a 1 year high of $63.20. The stock has a 50-day simple moving average of $34.70 and a 200-day simple moving average of $44.31. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. The stock has a market capitalization of $1.51 billion, a P/E ratio of 20.60, a PEG ratio of 1.37 and a beta of 1.20.

Institutional Trading of Astrana Health

Several hedge funds have recently bought and sold shares of the company. Nisa Investment Advisors LLC bought a new stake in shares of Astrana Health during the third quarter valued at approximately $35,000. KBC Group NV acquired a new stake in Astrana Health in the third quarter worth about $70,000. Pilgrim Partners Asia Pte Ltd acquired a new position in Astrana Health during the 4th quarter valued at about $40,000. Quarry LP bought a new stake in shares of Astrana Health during the 3rd quarter worth about $77,000. Finally, Quest Partners LLC acquired a new stake in shares of Astrana Health in the 3rd quarter worth approximately $133,000. 52.77% of the stock is currently owned by institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.